Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Otol Rhinol Laryngol. 2013 Mar;122(3):159-62.

Hyoid bone syndrome: a retrospective review of 84 patients treated with triamcinolone acetonide injections.

Author information

  • 1Department of Otolaryngology, Pontiac Osteopathic Hospital, Pontiac, Michigan, USA.

Abstract

OBJECTIVES:

We present a cohort of patients with hyoid bone syndrome who were treated with injections of triamcinolone acetonide (40 mg/mL), in order to raise awareness of this condition, validate its existence, and demonstrate the efficacy of this treatment.

METHODS:

We performed a retrospective chart review of patients who were given a diagnosis of and treated for hyoid bone syndrome by the senior author (A.D.R.) between 2006 and 2009.

RESULTS:

Eighty-four patients met the inclusion criteria. All patients presented with throat pain and had tenderness of 1 (63%) or both (38%) greater cornua of the hyoid bone. Seventy-four percent of the patients had complete resolution of symptoms with injection of the affected side(s), 15% had a partial response, and 10% had no response. One patient had a recurrence at 3 months and chose not to receive another treatment. Forty-five of the 62 patients with a complete response required only 1 injection. Forty-three patients (51%) also complained of dysphonia, only 5 of whom had additional laryngeal disorders that accounted for the dysphonia.

CONCLUSIONS:

Hyoid bone syndrome should be considered in patients who present with throat pain. Injection of triamcinolone into the affected greater cornu can confirm the diagnosis and resolve symptoms. A positive response to triamcinolone injection may obviate the need for additional testing and procedures.

PMID:
23577567
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk